Skip to main content
Top
Published in: Clinical and Translational Oncology 3/2017

01-03-2017 | Research Article

Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients

Authors: Mª A. Vaz Salgado, M. Soto, Mª E. Reguero, G. Muñoz, A. Cabañero, I. Gallego, S. Resano, F. Longo, A. Madariaga, A. Gomez, A. Carrato

Published in: Clinical and Translational Oncology | Issue 3/2017

Login to get access

Abstract

Background

Solitary fibrous tumors (SFTs) are a rare type of soft tissue sarcoma of unpredictable clinical behavior. Some clinicopathologic characteristics have also been related to patient outcome.

Methods

This study is a retrospective review of 30 patients. We analyzed the clinical course and pathological factors to predict recurrence.

Results

The mean age was 55.9 years. Forty-five percent were located in the thoracic region. The mean tumor size was 10 cm (max24). Thirty-three percent had a relapse and 20 % have died. Median time to relapse was 7.18 (1–13) years. Median overall survival (OS) was 15.5 years (0–32). On histopathologic analysis, 6 % percent had >4 mitoses, 23 % had necroses, and 36 % had atypia/pleomorphism. Forty-three percent had tumor size >10 cm. Forty-six percent had at least one characteristic of malignancy. None of this data could predict clinical behavior by itself.

Conclusions

SFT can be an aggressive disease and relapses can occur several years from diagnosis. We did not find any clinicopathologic factors that could predict the tumor behavior accurately. Nevertheless, it should be consider that we included different tumor locations and the sample size is small.
Literature
1.
go back to reference Gengler C, Guillou L. Solitary fibrous tumor and hemangiopericytoma: evolution of a concept. Histopathology. 2006;28:67–74. Gengler C, Guillou L. Solitary fibrous tumor and hemangiopericytoma: evolution of a concept. Histopathology. 2006;28:67–74.
2.
go back to reference Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995;26:440–9.CrossRefPubMed Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995;26:440–9.CrossRefPubMed
3.
go back to reference Gold JS, Antonescu CR, Hajdu C, Ferrone CR, Hussain M, Lewis JJ, et al. Clinocopathologic correlates of solitry fibrous tumor. Cancer. 2002;94(4):1057–8.CrossRefPubMed Gold JS, Antonescu CR, Hajdu C, Ferrone CR, Hussain M, Lewis JJ, et al. Clinocopathologic correlates of solitry fibrous tumor. Cancer. 2002;94(4):1057–8.CrossRefPubMed
4.
go back to reference Pitluk HC, Conn J Jr. Hemangiopericytoma. Literature review and clinical presentations. Am J Surg. 1979;137:413–6.CrossRefPubMed Pitluk HC, Conn J Jr. Hemangiopericytoma. Literature review and clinical presentations. Am J Surg. 1979;137:413–6.CrossRefPubMed
6.
go back to reference England MD, Hochholzer L, McCarthy MJ. Localized benig and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640–58.CrossRefPubMed England MD, Hochholzer L, McCarthy MJ. Localized benig and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640–58.CrossRefPubMed
7.
go back to reference Lahon B, Mercier O, Fadel E, Ghigna MR, Petkova B, Mussot S, et al. Solitary fibrous tumor of the pleura: outcomes of 157 complete resections in a single center. Ann Thorac Surg. 2012;94(2):394–400.CrossRefPubMed Lahon B, Mercier O, Fadel E, Ghigna MR, Petkova B, Mussot S, et al. Solitary fibrous tumor of the pleura: outcomes of 157 complete resections in a single center. Ann Thorac Surg. 2012;94(2):394–400.CrossRefPubMed
8.
go back to reference Fletcher CDM, Bridge JA, Hogendoorn P, Martens F. World Health Organization (WHO) classification of tumours of soft tissue and bone. Pathology and genetics. Lyon: IARC Press; 2013. Fletcher CDM, Bridge JA, Hogendoorn P, Martens F. World Health Organization (WHO) classification of tumours of soft tissue and bone. Pathology and genetics. Lyon: IARC Press; 2013.
9.
go back to reference Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011;117:4939–47.CrossRefPubMedPubMedCentral Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011;117:4939–47.CrossRefPubMedPubMedCentral
10.
go back to reference Guillerme F, Truntzer P, Prim N, Chenard MP, Voirin J, Noël G. Solitary fibrous tumors: case report of a late relapse. Cancer Radiother. 2011;15:330–3.CrossRefPubMed Guillerme F, Truntzer P, Prim N, Chenard MP, Voirin J, Noël G. Solitary fibrous tumors: case report of a late relapse. Cancer Radiother. 2011;15:330–3.CrossRefPubMed
11.
go back to reference Park CK, Lee DH, Park JY, Park SH, Kwon KY. Multiple recurrent malignant solitary fibrous tumors: long-term follow-up of 24 years. Ann Thorac Surg. 2011;91:1285–8.CrossRefPubMed Park CK, Lee DH, Park JY, Park SH, Kwon KY. Multiple recurrent malignant solitary fibrous tumors: long-term follow-up of 24 years. Ann Thorac Surg. 2011;91:1285–8.CrossRefPubMed
12.
go back to reference Mohamed H, Mandal AK. Natural history of multifocal solitary fibrous tumors of the pleura: a 25-year follow-up report. J Natl Med Assoc. 2004;96:659–62.PubMedPubMedCentral Mohamed H, Mandal AK. Natural history of multifocal solitary fibrous tumors of the pleura: a 25-year follow-up report. J Natl Med Assoc. 2004;96:659–62.PubMedPubMedCentral
13.
go back to reference Oliaro A, Filosso PL, Casadio C, Ruffini E, Cianci R, Porrello C, et al. Il mesotelioma fibroso benigno della pleura. Minerva Chir. 1994;49:1311–6.PubMed Oliaro A, Filosso PL, Casadio C, Ruffini E, Cianci R, Porrello C, et al. Il mesotelioma fibroso benigno della pleura. Minerva Chir. 1994;49:1311–6.PubMed
14.
go back to reference Masson EA, MacFarlane IA, Graham D, Foy P. Spontaneous hypoglicemia due to a pleural fibroma: role of insulin like growth factors. Thorax. 1991;46:930–1.CrossRefPubMedPubMedCentral Masson EA, MacFarlane IA, Graham D, Foy P. Spontaneous hypoglicemia due to a pleural fibroma: role of insulin like growth factors. Thorax. 1991;46:930–1.CrossRefPubMedPubMedCentral
15.
go back to reference de Perrot M, Fischer S, Bründler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg. 2002;74:285–93.CrossRefPubMed de Perrot M, Fischer S, Bründler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg. 2002;74:285–93.CrossRefPubMed
16.
go back to reference Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component—is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314–21.CrossRefPubMed Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component—is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314–21.CrossRefPubMed
17.
go back to reference Tapias LF, Mino-Kenudson M, Lee H, Wright C, Gaissert HA, Wain JC, et al. Risk factor analysis for the recurrence of resected solitary fibrous tumors of the pleura: a 33-year experience and proposal for a scoring system. Eur J Cardiothorac Surg. 2013;44(1):111–7. doi:10.1093/ejcts/ezs629.CrossRefPubMed Tapias LF, Mino-Kenudson M, Lee H, Wright C, Gaissert HA, Wain JC, et al. Risk factor analysis for the recurrence of resected solitary fibrous tumors of the pleura: a 33-year experience and proposal for a scoring system. Eur J Cardiothorac Surg. 2013;44(1):111–7. doi:10.​1093/​ejcts/​ezs629.CrossRefPubMed
18.
go back to reference Baldi GG, Stacchiotti S, Mauro V, Dei Tos AP, Gronchi A, Pastorino U, et al. Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res. 2013;3:4–11.CrossRefPubMedPubMedCentral Baldi GG, Stacchiotti S, Mauro V, Dei Tos AP, Gronchi A, Pastorino U, et al. Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res. 2013;3:4–11.CrossRefPubMedPubMedCentral
19.
go back to reference Magdeleinat P, Alifano M, Petino A, Le Rochais JP, Dulmet E, Galateau F, et al. Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome. Eur J Cardio Thorac Surg. 2002;21:1087–93.CrossRef Magdeleinat P, Alifano M, Petino A, Le Rochais JP, Dulmet E, Galateau F, et al. Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome. Eur J Cardio Thorac Surg. 2002;21:1087–93.CrossRef
20.
go back to reference Rena O, Filosso PL, Papalia E, Molinatti M, Di Marzio P, Maggi G, et al. Solitary fibrous tumors of the pleura: surgical treatment. Eur J Cardio Thorac Surg. 2001;19:185–9.CrossRef Rena O, Filosso PL, Papalia E, Molinatti M, Di Marzio P, Maggi G, et al. Solitary fibrous tumors of the pleura: surgical treatment. Eur J Cardio Thorac Surg. 2001;19:185–9.CrossRef
21.
go back to reference Cardillo G, Facciolo F, Cavazzana AO, Capece G, Gasparri R, Martelli M. Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients. Ann Thorac Surg. 2000;70:1808–12.CrossRefPubMed Cardillo G, Facciolo F, Cavazzana AO, Capece G, Gasparri R, Martelli M. Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients. Ann Thorac Surg. 2000;70:1808–12.CrossRefPubMed
22.
go back to reference Brozzetti S, DÁndrea N, Limit MR, Pisanelli MC, De Angelis R, Carvallo A. Clinical behavior of solitary fibrous tumors of the pleura: an inmunohistochemical study. Anticancer Res. 2000;20:4701–6.PubMed Brozzetti S, DÁndrea N, Limit MR, Pisanelli MC, De Angelis R, Carvallo A. Clinical behavior of solitary fibrous tumors of the pleura: an inmunohistochemical study. Anticancer Res. 2000;20:4701–6.PubMed
23.
go back to reference Brunnemann RB, Ro JY, Ordonez NG, Mooney J, El-Naggar AK, Ayala AG. Extrapleural solitary fibrous tumor: a clinic-pathologic study of 24 cases. Mod pathol. 1999;12:1034–42.PubMed Brunnemann RB, Ro JY, Ordonez NG, Mooney J, El-Naggar AK, Ayala AG. Extrapleural solitary fibrous tumor: a clinic-pathologic study of 24 cases. Mod pathol. 1999;12:1034–42.PubMed
24.
go back to reference Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25(9):1298–306.CrossRefPubMed Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25(9):1298–306.CrossRefPubMed
25.
go back to reference Lococo F, Cusumano G, Margaritora S, Cardillo G, Filosso P, Cesario A. Tapias score for predicting recurrences in resected solitary fibrous tumor of the pleura: controversial points and future perspectives emerging from an external validation. Chest. 2015;147(3):e115–6.CrossRefPubMed Lococo F, Cusumano G, Margaritora S, Cardillo G, Filosso P, Cesario A. Tapias score for predicting recurrences in resected solitary fibrous tumor of the pleura: controversial points and future perspectives emerging from an external validation. Chest. 2015;147(3):e115–6.CrossRefPubMed
26.
go back to reference Schirosi L, Lantuejoul S, Cavazza A, Murer B, Yves Brichon P, Migaldi M, et al. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR. Am J Surg Pathol. 2008;32(11):1627–42.CrossRefPubMed Schirosi L, Lantuejoul S, Cavazza A, Murer B, Yves Brichon P, Migaldi M, et al. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR. Am J Surg Pathol. 2008;32(11):1627–42.CrossRefPubMed
27.
go back to reference Saifuddin A, Da Costa P, Chalmers AG, Carey BM, Robertson RJ. Primary malignant localized fibrous tumors of the pleura: clinical, radiological, and pathological features. Clin Radiol. 1992;45:13–7.CrossRefPubMed Saifuddin A, Da Costa P, Chalmers AG, Carey BM, Robertson RJ. Primary malignant localized fibrous tumors of the pleura: clinical, radiological, and pathological features. Clin Radiol. 1992;45:13–7.CrossRefPubMed
28.
go back to reference Park MS, Patel S, Ravi V, Conley AP, Trent JC, Lazar AJF, et al. The role of chemotherapy in advanced hemangipeicytoma/solitary fibrous tumor. J Clin Oncol. 2011; 29, abstr 10097. Park MS, Patel S, Ravi V, Conley AP, Trent JC, Lazar AJF, et al. The role of chemotherapy in advanced hemangipeicytoma/solitary fibrous tumor. J Clin Oncol. 2011; 29, abstr 10097.
29.
go back to reference Khalifa J, Ouali M, Chaltiel L, Le Guellec S, Le Cesne A, Blay JY, Cousin P, Chaigneau L, Bompas E, Piperno-Neumann S, Bui-Nguyen B, Rios M, Delord JP, Penel N, Chevreau C. Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. BMC Cancer. 2015;15(15):700.CrossRefPubMedPubMedCentral Khalifa J, Ouali M, Chaltiel L, Le Guellec S, Le Cesne A, Blay JY, Cousin P, Chaigneau L, Bompas E, Piperno-Neumann S, Bui-Nguyen B, Rios M, Delord JP, Penel N, Chevreau C. Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. BMC Cancer. 2015;15(15):700.CrossRefPubMedPubMedCentral
Metadata
Title
Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients
Authors
Mª A. Vaz Salgado
M. Soto
Mª E. Reguero
G. Muñoz
A. Cabañero
I. Gallego
S. Resano
F. Longo
A. Madariaga
A. Gomez
A. Carrato
Publication date
01-03-2017
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 3/2017
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-016-1536-7

Other articles of this Issue 3/2017

Clinical and Translational Oncology 3/2017 Go to the issue

Acknowledgement to Reviewers

Thanks to reviewers

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine